Analogs of n,n,n-trimethyl-4-phosphoryloxytryptamine
US-2024400512-A1 · Dec 5, 2024 · US
US8932557B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8932557-B2 |
| Application number | US-201213477095-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 22, 2012 |
| Priority date | Feb 14, 2008 |
| Publication date | Jan 13, 2015 |
| Grant date | Jan 13, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed here in are compounds and methods of diagnosing Alzheimer's Disease or a predisposition thereto in a mammal, the method comprising administering to the mammal a diagnostically effective amount of a radiolabeled compound, wherein the compound is selected from the group consisting of radiolabeled carbazoles and derivatives thereof and triazoles derivatives, allowing the compound to distribute into the brain tissue, and imaging the brain tissue, wherein an increase in binding of the compound to the brain tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing Alzheimer's Disease.
Opening claim text (preview).
We claim: 1. A compound that is: or pharmaceutically acceptable salts thereof, wherein R 21 is selected from the group consisting of F, Cl, Br, I, 18 F, 77 Br, 123 I, 124 I, 125 I, 131 I, and NO 2 . 2. A compound which is: 7-(6-Nitropyridine-3-yl)-5H-pyrido[4,3-b]indole; or pharmaceutically acceptable salts thereof. 3. A compound that is 7-[6-( 18 F)fluoropyridin-3-yl]-5H-pyrido[4,3-b]indole: or a pharmaceutically acceptable salt thereof. 4. A compound that is 7-[6-fluoropyridin-3-yl]-5H-pyrido[4,3-b]indole: or a pharmaceutically acceptable salt thereof. 5. A process for the preparation of 7-[6-( 18 F)fluoropyridin-3-yl]-5H-pyrido[4,3-b]indole, comprising reacting 7-(6-nitropyridine-3-yl)-5H-pyrido[4,3-b]indole with anhydrous [F-18]fluoride ion.
Ortho-condensed systems · CPC title
Heterocyclic compounds · CPC title
Ortho-condensed systems · CPC title
having six-membered rings with one nitrogen as the only ring hetero atom · CPC title
having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.